IBC
19.9.2018 12:05:11 CEST | Business Wire | Press release
IBC2018 has closed its doors for this year and has delivered another great event with visitor figures of 55,884. As well as providing a host of new initiatives this year, the exhibition grew by 667m2 and conference delegates were up by 14% year on year. One of the most important growth figures lies in the diversity of its content with a targeted effort increasing women speakers at the conference up from 14% to 37%.
The IBC International Honour for Excellence saw its first-ever woman recipient this year, too. Joan Ganz Cooney was the co-creator of the global phenomenon that is Sesame Street , 50 years ago and her trophy was collected on her behalf by one of the street’s longest residents, Ernie.
The IBC App has provided real networking opportunities, with more than 91,000 interactions on the matchmaking platform. In addition, IBC trended number one on Twitter in the Netherlands on several days of the convention, with 185 million potential impressions and over 250,000 video views. Engagement with IBC has also increased on a year-round basis with IBC365 – the site now has over 55,000 subscribers averaging 49,000 active users per month.
Michael Crimp, IBC’s CEO, comments; “The show is about engagement, engagement, engagement. The stats are up in almost all areas and re-bookings are ahead of last year. IBC is much more than a trade show, we have developed a basket of data-driven statistics including sales leads generated on stands, conference attendance and IBC365 views and this sharing of information is pivotal to the longevity of IBC’s success and sits at the core of the organisation.”
“All of the initiatives this year have been aimed at bringing together the best minds, the original thinkers, to network and share their knowledge. As all communication becomes video and audio, IBC continues to be the place to debate the future of media, technology and entertainment,” adds Crimp.
Guiding the renewed focus this year was a new content steering group, drawn from across the industry, and chaired by Keith Underwood, Chief Operating Officer at Channel 4 in the UK.
IBC head of content Jaisica Lapsiwala, said, “This year, we have worked closely with the industry to create a programme that is not only reflective of the changes in the ecosystem, but which also paves a path forward for our industry. This has resulted in an engaging and diverse 2018 edition of IBC. An example of this was our Global Gamechangers day which brought creative, technology and business chiefs such as Zahra Rasool from Al Jazeera, Peter Salmon from Endemol and Lindsay Pattison from WPP to the stage. Threaded through the programme were the cutting-edge technologies transforming the industry. Blockchain is a great example, with a keynote from Kim Jackson of Singular DTV and papers from people who are already implementing it, like Éric Minoli of Groupe Média TFO.”
Alongside the conference, IBC hosted three invitation-only executive forums. The Leaders’ Forum looked to the future, considering what the new ecosystem could be following consolidation, acquisition and collaboration. The Cyber Security Forum considered not just the threats but how to respond to them. New to the programme this year was the Telco and Media Innovation Forum, a vital point of debate as the boundaries between media and communication blur.
Once again, IBC was the venue for an examination of the intersection of craft and technology in The Big Screen. Sessions included an in-depth look at the effects in Game of Thrones and Pixar’s Dominic Glynn talking about the animation marvel that is The Incredibles 2 – and how things have changed in the 14 years since the original movie.
The Future Zone is always a busy part of IBC, with presentations from researchers and academic bodies developing the ideas which may become the hit products five years from now. This year saw the addition of a theatre stage, presented by one of IBC’s owners, IABM, with a rolling programme of presentations discussing the ideas in more detail.
As well as the IBC Big Screen, the IABM Future Trends Theatre and the Content Everywhere Hub, staged presentations and enlarged on-stand meeting areas are becoming an increasingly common feature of exhibition stands throughout the show. “As the industry has moved on from big boxes handling discrete functions towards a software-based world that looks across the content supply chain, so the way vendors present themselves and interact with visitors at IBC has changed,” said Roger Thornton, chair of the IBC exhibition committee.
“Today, it’s all about collaboration to deliver solutions that give broadcast and media companies the agility and flexibility they need to keep ahead in this rapidly transforming media landscape. That’s why we’re seeing more and more companies using big-picture theatre presentations on their stands and providing large meeting areas where the conversations that kick off the collaboration get started.”
IBC2019 starts with the first day of conference sessions on Thursday 12 September, running until the exhibition closes on Tuesday 17 September.
-ENDS-
Notes to Editors:
About IBC
IBC is the world’s most influential media,
entertainment and technology show, attracting 55,000+ attendees from
more than 170 countries and combining a highly respected and
peer-reviewed conference with an exhibition that showcases 1,700+
leading industry suppliers of state-of-the-art technology. In addition
to the world-class exhibition and conference, IBC also encompasses the
IBC Daily, IBCTV and IBC365.
IBC365 provides year-round insight and opinion into the hot topics and key trends from leading industry journalists, along with insightful whitepapers, peer reviewed technical papers, highly engaging webinars and an expansive video library.
IBC2019 Dates
| Conference: | 12 - 16 September 2019 | ||||
| Exhibition: | 13 - 17 September 2019 |
For more information about IBC2019 visit: show.ibc.org/
View source version on businesswire.com: https://www.businesswire.com/news/home/20180919005306/en/
Contact:
Bubble Agency Louise Wells E: louisew@bubbleagency.com T: +44 7718 985 252
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
